Stewart, A. Keith
Krishnan, Amrita Y.
Singhal, Seema
Boccia, Ralph V.
Patel, Manish R.
Niesvizky, Ruben
Chanan-Khan, Asher A.
Ailawadhi, Sikander
Brumm, Jochen
Mundt, Kirsten E.
Hong, Kyu
McBride, Jacqueline
Shon-Nguyen, Quyen
Xiao, Yuanyuan
Ramakrishnan, Vanitha
Polson, Andrew G.
Samineni, Divya
Leipold, Douglas
Humke, Eric W.
McClellan, James Scott
Berdeja, Jesus G.
Article History
Received: 20 April 2018
Revised: 6 August 2018
Accepted: 17 August 2018
First Online: 4 February 2019
Conflict of interest
: A.K.S.: Consulting roles at Celgene, Amgen, Janssen, BMS, and Roche. S.S.: Speakers’ bureau for Celgene and Millennium Pharmaceuticals. R.V.B.: Speaker’s bureau for Celgene, Takeda, BMS, and Amgen. M.R.P.: Speaker’s bureau for Celgene, Exelixis, and Genentech. J.B., K.E.M., K.H., J.M., Q.S.N., Y.X., A.G.P., D.S., D.L., E.W.H., and J.S.M.: Employee of Genentech, Inc. and shareholders of F. Hoffmann La Roche, Ltd. V.R.: Former employee of Genentech, Inc. and shareholders of F. Hoffmann La Roche, Ltd. Current employee of BeiGene, USA. J.G.B.: Research funding from Genentech, Abbvie, Amgen, Bluebird, BMS, Celgene, Constellation, Curis, Janssen, Novartis, Takeda, and Teva. A.Y.K., R.N., A.A.C.K., and S.A. declare that they have no conflict of interest.